SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Cass Alan)
 

Search: WFRF:(Cass Alan) > (2018) > Prognostic utility ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Mafham, Marion M (author)

Prognostic utility of estimated albumin excretion rate in chronic kidney disease : results from the Study of Heart and Renal Protection

  • Article/chapterEnglish2018

Publisher, publication year, extent ...

  • 2017-01-14
  • Oxford University Press,2018
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-342348
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-342348URI
  • https://doi.org/10.1093/ndt/gfw396DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Background: Estimated albumin excretion rate (eAER) provides a better estimate of 24-h albuminuria than albumin:creatinine ratio (ACR). However, whether eAER is superior to ACR in predicting end-stage renal disease (ESRD), vascular events (VEs) or death is uncertain.Methods: The prognostic utility of ACR and eAER (estimated from ACR, sex, age and race) to predict mortality, ESRD and VEs was compared using Cox proportional hazards regression among 5552 participants with chronic kidney disease in the Study of Heart and Renal Protection, who were not on dialysis at baseline.Results: During a median follow-up of 4.8 years, 1959 participants developed ESRD, 1204 had a VE and 1130 died (641 from a non-vascular, 369 from a vascular and 120 from an unknown cause). After adjustment for age, sex and eGFR, both ACR and eAER were strongly and similarly associated with ESRD risk. The average relative risk (RR) per 10-fold higher level was 2.70 (95% confidence interval 2.45-2.98) for ACR and 2.67 (2.43-2.94) for eAER. Neither ACR nor eAER provided any additional prognostic information for ESRD risk over and above the other. For VEs, there were modest positive associations between both ACR and eAER and risk [adjusted RR per 10-fold higher level 1.37 (1.22-1.53) for ACR and 1.36 (1.22-1.52) for eAER]. Again, neither measure added prognostic information over and above the other. Similar results were observed when ACR and eAER were related to vascular mortality [RR per 10-fold higher level: 1.64 (1.33-2.03) and 1.62 (1.32-2.00), respectively] or to non-vascular mortality [1.53 (1.31-1.79) and 1.50 (1.29-1.76), respectively].Conclusions: In this study, eAER did not improve risk prediction of ESRD, VEs or mortality.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Staplin, Natalie (author)
  • Emberson, Jonathan (author)
  • Haynes, Richard (author)
  • Herrington, William (author)
  • Reith, Christina (author)
  • Wanner, Christoph (author)
  • Walker, Robert (author)
  • Cass, Alan (author)
  • Levin, Adeera (author)
  • Fellström, Bengt,1947-Uppsala universitet,Njurmedicin(Swepub:uu)bengfell (author)
  • Jiang, Lixin (author)
  • Holdaas, Hallvard (author)
  • Kasiske, Bertram (author)
  • Wheeler, David C (author)
  • Landray, Martin J (author)
  • Baigent, Colin (author)
  • Uppsala universitetNjurmedicin (creator_code:org_t)

Related titles

  • In:Nephrology, Dialysis and Transplantation: Oxford University Press33:2, s. 257-2640931-05091460-2385

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view